Medicamen Organics share price
You have to be logged in to add this to Watchlist.- ₹21.00(-2.33%)June 5, 2026 14:10:33 PM IST
- NSE
- BSE
- Vol : 16.00 K (NSE + BSE)Last 20 day avg : 20.00 K
Medicamen Organics is trading -2.33% lower at Rs 21.00 as compared to its last closing price. Medicamen Organics has been trading in the price range of 22.00 & 21.00. Medicamen Organics has given -10.42% in this year & -10.60% in the last 5 days. Listed peers of Medicamen Organics include Sun Pharmaceutical Industries (0.48%), Torrent Pharmaceuticals (2.07%), Cipla (0.21%).The Mutual Fund holding in Medicamen Organics was at -% in . The MF holding has - from the last quarter. The FII holding in Medicamen Organics was at 0.07% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 06, 2026, 04:28 PM UTC
- Debt To EquityHigher than industry0.50The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,787.95 | 0.48 | 4,29,206.85 | 38.28 | 6.09 | 0.90 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,427.50 | 2.07 | 1,49,823.55 | 76.60 | 19.45 | 0.80 | 17.62 |
| Cipla | Moderately Bullish | 1,400.70 | 0.21 | 1,13,239.21 | 20.90 | 3.53 | 0.95 | 0.81 |
| Divi's Laboratories | Neutral | 6,625.45 | 0.47 | 1,76,150.12 | 81.10 | 11.89 | 0.45 | 0.01 |
| Lupin | Neutral | 2,265.00 | 0.72 | 1,03,561.68 | 33.60 | 6.53 | 0.49 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-03-13 | To consider Fund Raising |
| 2025-11-14 | Quarterly Results |
| 2025-05-29 | Audited Results |
| 2025-01-08 | To consider Fund Raising |
- IndustryBiotechnology & Drugs
- ISININE0PE401018
- BSE Code
- NSE CodeMEDIORG
Medicamen Organics is trading at 21.00 as on Fri Jun 05 2026 08:40:33. This is -2.33% lower as compared to its previous closing price of 21.50.
The market capitalization of Medicamen Organics is 25.55 Cr as on Fri Jun 05 2026 08:40:33.
The 52 wk high for Medicamen Organics is 49.70 whereas the 52 wk low is 19.50
Medicamen Organics can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 26.32
- Dividend Yield: 0.00%
- D/E ratio: 0.50
Medicamen Organics reported a net profit of -4.02 Cr in 2026.
EQUITY QUICK LINKS
Medicamen Organics QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.